CYP46A1 functional promoter haplotypes decipher genetic susceptibility to Alzheimer's disease

8Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We here demonstrate that promoter polymorphisms rs8003602 and rs3783320 of cholesterol 24S-hydroxylase (CYP46A1) were significantly associated with Alzheimer's disease (AD) in Chinese subjects. Haplotype analyses showed that haplotype CG is the risk haplotype. Either single marker or haplotypic association was found only in the APOE ε4 negative group. The association was then replicated in an independent set of case-control samples in Mongolians. We also investigated the function of promoter haplotypes and found that luciferase expression for TA promoter construct exhibited significantly higher expression level than the risk CG promoter construct. This finding might indicate individuals bearing the CG haplotype are genetically more susceptible to AD compared to those with TA haplotype. Further, we found MYT1 could be the potential transcription factor binding to the significant promoter polymorphism and mediated gene transcriptional activity. In general, our results show that promoter haplotypes could significantly affect CYP46A1 gene transcription level possibly through interacting with certain transcription factors. © 2010 IOS Press and the authors. All rights reserved.

Cite

CITATION STYLE

APA

Li, Y., Chu, L. W., Wang, B., Yik, P. Y., Huriletemuer, Jin, D. Y., … Song, Y. Q. (2010). CYP46A1 functional promoter haplotypes decipher genetic susceptibility to Alzheimer’s disease. Journal of Alzheimer’s Disease, 21(4), 1311–1323. https://doi.org/10.3233/JAD-2010-100765

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free